[Rosette E and active rosette E tests in the evaluation of cell-mediated immunity in uremic patients].
To evaluate cellular immunity in uremia, we studied 235 uremic patients (178 on regular hemodialysis and 57 on medical treatment). E-rosettes were significantly lower (p less than 0.01) in all patients. The active E-rosettes test was found less significant to study T lymphocyte markers. The kind of correlations made with primary disease, small molecule levels, rehabilitation, suggests that cell-mediated immunodeficiency in uremia is a premature phenomenon and scarcely influenced by adequate hemodialysis treatment.
D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000209:etiology; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis; D012397:Rosette Formation; D014511:Uremia / Q000150:complications / Q000276:immunology* / Q000628:therapy
Il test delle rosette E e delle rosette E attive nella valutazione dell'immunità cellulo-mediata nell'uremico.